YAP1 is pervasively activated in human cancers including ESCC, where its activation is required to instruct malignant properties, such as chemoresistance and metastasis.6, 26 To determine the effect of SOX2 on the motility of ESCC cells, Transwell assays were performed. The gene discussed is SOX2; the disease is cancer.